Eurofins CDMO

Drug development and manufacturing for biologics and small molecules, with integrated services from preclinical, clinical to commercial. 

Why Eurofins CDMO

Scientific expertise

Expand_img

With over two decades of expertise, we deliver integrated drug development and manufacturing services, ensuring seamless pathways for your programme from preclinical to commercialisation

Diverse programmes, flexible CDMO

Expand_img

We are proud to serve a diverse range of clients, from early-stage startups to pharmaceutical companies, providing individualised, flexible and high-quality service to all.

Integrated, customised solutions

Expand_img

Currently manufacturing several API (Active Pharmaceutical Ingredient) products, we combine expertise in small molecules, biologics, and ADCs with specialised services designed to de-risk and accelerate product development.

Strong quality and management systems

Expand_img

Underpinned by a strong quality and project management system, our team of experts navigate complex regulatory compliance within quality frameworks with a focus on timeline, budget and communication

Find a site near you!

Getting the map ready...

Tuesday, May 27, 2025

Biologics brochure - Eurofins CDMO Alphora

Biologics services - North America

Tuesday, July 09, 2024

Eurofins CDMO Alphora Inc. (Canada) Announces Completion of New API Manufacturing Facility News

Eurofins CDMO is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility.

Wednesday, May 29, 2024

Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory News

Eurofins CDMO Alphora Inc. is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory

adobestock_528567825-1

Let's advance your innovation together

Careers Section Background Image
Search Icon
eurofins-cdmo_img-1367